Ashwagandha (Withania somnifera) and Shunthi (Zingiber officinale) in mild and moderate COVID-19: An open-label randomized controlled exploratory trial

• Main Authors: Harbans Singh (Author), Babita Yadav (Author), Amit K. Rai (Author), Sumit Srivastava (Author), AJV Saiprasad (Author), Sophia Jameela (Author), Richa Singhal (Author), Sanuj Muralidharan (Author), Rijin Mohan (Author), Shikha Chaudhary (Author), Rakesh Rana (Author), Shruti Khanduri (Author), Bhagwan S. Sharma (Author), Bhogavalli Chandrasekhararao (Author), Narayanam Srikanth (Author), Kartar S. Dhiman (Author)
• Format: Bog
• Udgivet: Elsevier, 2023-09-01T00:00:00Z.
• Fag: article
• Online adgang: Connect to this object online.

Background: Ayurveda interventions have been used for prophylaxis and care during the COVID-19 pandemic in India and have shown promising results in promoting early clinical recovery from COVID-19. Objective: To assess the efficacy and safety of Ashwagandha [Withania somnifera (L.) Dunal] tablet and...